Provided by Tiger Trade Technology Pte. Ltd.

Propanc Biopharma, Inc.

0.4940
-0.0183-3.57%
Post-market: 0.4925-0.0015-0.30%19:38 EDT
Volume:134.49K
Turnover:67.94K
Market Cap:3.13M
PE:-0.03
High:0.5215
Open:0.5160
Low:0.4714
Close:0.5123
52wk High:52.50
52wk Low:0.4714
Shares:6.33M
Float Shares:1.25M
Volume Ratio:0.50
T/O Rate:10.76%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-17.6157
EPS(LYR):-371.2241
ROE:-161.86%
ROA:-70.14%
PB:0.33
PE(LYR):0.00

Loading ...

Sep 25, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jul 17, 2026

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jul 14, 2026

Major Issues Report

Form 8-K - Current report
May 14, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 16, 2026

Correspondence

Form CORRESP - Correspondence
Apr 10, 2026

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Feb 26, 2026

Major Issues Report

Form 8-K - Current report
Feb 20, 2026

Correspondence

Form CORRESP - Correspondence
Feb 19, 2026

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Feb 17, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 13, 2026

Correspondence

Form CORRESP - Correspondence
Feb 11, 2026

Correspondence

Form CORRESP - Correspondence
Feb 02, 2026

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jan 07, 2026

Major Issues Report

Form 8-K - Current report
Jan 07, 2026

Correspondence

Form CORRESP - Correspondence
Dec 30, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Nov 14, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 10, 2025

Major Issues Report

Form 8-K - Current report
Oct 14, 2025

Major Issues Report

Form 8-K - Current report
Sep 29, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]